Timothy J. Yeatman, MD
Dr. Timothy Yeatman currently serves as President of the Gibbs Research Institute and leads the Gibbs Cancer Center as its new Director. He has previously held numerous positions at the Moffitt Cancer Center that, during his 20 year tenure, has grown to become one of the nation's top three cancer National Cancer Institute (NCI) comprehensive cancer centers. Dr. Yeatman has previously also served as the Executive Vice President for Translational Research, Professor of Surgery and Oncologic Sciences, and Section Head of Hepatobiliary Surgery, as well as the President and Founding Chief Scientific Officer for M2Gen, a subsidiary of the Moffitt Cancer Center. Most recently, he was named Chief Scientific Officer for the Center for Advanced of Science in Space (CASIS), a non-profit organization appoint by Congress and funded by NASA to oversee scientific use of the International Space Station.
Dr. Yeatman is a pioneer in personalized medicine, having established the world's largest human tumor bio-repository and database with comprehensive molecular profiling of approximately 20,000 tumor specimens. He has helped to deliver personalized cancer care by utilizing this large analysis of cancers. Dr. Yeatman has received numerous honors and awards including the James IV Association of Surgeons Traveling Fellowship, Europe; the Center Director's Award for Outstanding Research at Moffitt Cancer Center; and the James Ewing Foundation Trainee Award, Society of Surgical Oncology, and the "Million Dollar Researcher" Award at the University of South Florida. He has published more than 200 articles in the op peer-reviewed journals in his field including the prestigious Science, Nature Genetics, Nature Medicine, Nature Reviews Cancer, as well as the Journal of the National Cancer Institute, and Cancer Research.
Sign up for
Follow the medications that matter most to
you and Ask related questions.
Receive email notifications as soon as your
medication pages are updated.